Bermekimab
| Bermekimab | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | |
| Routes of administration | intravenous |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 1401965-15-8 |
| PubChem | |
| DrugBank | |
| ChemSpider | none |
| KEGG | D11253 |
Bermekimab<ref>Statement On A Nonproprietary Name Adopted By The USAN Council - Bermekimab, American Medical Association.</ref> (MABp1, trade name Xilonix) is a human monoclonal antibody of IgG1k isotype targeting Interleukin 1 alpha (IL1A).<ref>,
MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study, The Lancet Oncology, Vol. 15(Issue: 6), DOI: 10.1016/S1470-2045(14)70155-X, Full text,</ref> As of 2017[update][[Category:Articles containing potentially dated statements from Expression error: Unexpected < operator.]], bermekimab is in phase III clinical trials as an immunotherapy for colorectal cancer<ref>
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer (XCITE)(link). ClinicalTrials.gov. U.S. National Institutes of Health.
</ref> and as of September 2018 in phase II clinical trials for the treatment of atopic dermatitis.<ref>
A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic Dermatitis(link). ClinicalTrials.gov. U.S. National Institutes of Health.
</ref>
Bermekimab is being developed by XBiotech Inc.<ref>
Xilonix™ True Human™ monoclonal antibody by Xbiotech oncology(link). www.xbiotech.com. XBiotech.
</ref>
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
| This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
